Follow-up strategies in focal liver lesions and treatment methods
Yükleniyor...
Tarih
2021
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Scientific Research and Community
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Today, advances in cross-sectional imaging have led to the detection and early recognition of incidental/focal liver lesions (FCL). In approximately 17,000 cases of chest CT, incidental liver lesions were found in 6% [1]. In general, FCL consists of hepatocytes, biliary epithelium, mesenchymal tissue, connective tissue, or metastasized cells from distant sites. Most incidental lesions are benign, some may require careful management and treatment. In evaluating the lesion, the patient’s clinical history, underlying disease and age factor should be considered. FCL can be detected at a rate of 10-30% in normal healthy and chronic liver disease patients, and even in oncology patients with malignancy, FCLs can be highly benign (50-80%).
Açıklama
Anahtar Kelimeler
Focal Liver Lesions, Follow-Up
Kaynak
Journal of Gastroenterology & Hepatology Reports
WoS Q Değeri
Scopus Q Değeri
Cilt
2
Sayı
4
Künye
Göral, V., Kerem, M., Göral, & Örmeci, N. (2021). Follow-up strategies in focal liver lesions and treatment methods. Journal of Gastroenterology & Hepatology Reports, 2(4), pp. 1–6. https://doi.org/10.47363/JGHR/2021(2)123
